From a higher bar for regulatory clearance to pricing limitations, drug development is more expensive than ever. This has led ...

In an effort to become more nimble, some companies, like Bayer Pharmaceutical, are getting rid of middle managers.

For pharma, an industry in which gross margins are among the highest in the S&P 500, labor was never really the reason for moving offshore to places like Ireland—it was always about playing the ...

AI won’t deliver until CIOs fix the data stack, as half of the CEOs in an IBM study admit the AI rush has left their tech stacks fragmented. In a rush to capitalize on AI, CEOs are hitting a ...

Biopharmaceutical giants Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Neurocrine Biosciences Inc (NASDAQ:NBIX) are fresh out of the earnings confessional, with very different results. Vertex saw a ...

Bristol Myers Squibb is yet another example of a Big Pharma company pledging a multibillion dollar investment in the U.S. as the Trump administration tries to woo drugmakers to boost their domestic ...

In this article, we are going to take a look at where Matrix Service Company (NASDAQ ... Strong quarterly results from some of the big tech giants are helping alleviate concerns about the ...

Back in February, experts expressed concerns to Forbes about the cost and production times associated with mining raw materials, and some said the mining might not result in a huge payoff.

The company reported $70.1 billion in revenue and earnings per share of $3.46. Strong demand in Cloud services and AI infrastructure drove big growth, Microsoft's CEO said. Microsoft reported it ...

A bipartisan group of congressional lawmakers introduced a bill Monday to eliminate a tax deduction pharmaceutical companies receive ... The loophole allowing Big Pharma to write off advertising ...

Sun Pharma was one of the few companies to in license products from big pharma to enter the specialty segment.” Thus, Sun Pharma acquired worldwide rights to Ilumya from Merck for $80 million in ...